Itau Unibanco Holding S.A. Coherus Bio Sciences, Inc. Transaction History

Itau Unibanco Holding S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$16.33 - $21.37 $16,150 - $21,134	-989 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$13.1 - $22.1 $25,990 - $43,846	-1,984 Reduced 66.73%	989 $22,000
Q4 2018 Feb 13, 2019	SELL	$8.65 - $16.28 $25 - $48	-3 Reduced 0.1%	2,973 $26,000
Q3 2018 Nov 13, 2018	SELL	$14.45 - $20.25 $1,199 - $1,680	-83 Reduced 2.71%	2,976 $49,000
Q2 2018 Aug 13, 2018	SELL	$10.25 - $17.45 $8,702 - $14,815	-849 Reduced 21.72%	3,059 $43,000
Q1 2018 May 14, 2018	BUY	$9.1 - $13.7 $25,216 - $37,962	2,771 Added 243.71%	3,908 $43,000
Q4 2017 Feb 09, 2018	BUY	$8.35 - $14.4 $1,185 - $2,044	142 Added 14.27%	1,137 $10,000
Q3 2017 Nov 14, 2017	BUY	$11.1 - $14.5 $11,044 - $14,427	995	995 $42,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $118M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.